High prevalence and incidence of sexually transmitted infections among women living in Kwazulu-Natal, South Africa

Sarita Naidoo, Handan Wand, Nathlee Samantha Abbai, Gita Ramjee, Sarita Naidoo, Handan Wand, Nathlee Samantha Abbai, Gita Ramjee

Abstract

Background and objectives: Sexually transmitted infections (STIs) contribute largely to the burden of health in South Africa and are recognized as major contributors to the human immunodeficiency virus (HIV) epidemic. Young women are particularly vulnerable to STIs. The purpose of this secondary analysis was to examine the risk factors associated with prevalent and incident STIs among women who had participated in three clinical trials.

Methods: A total of 5,748 women were screened and 2293 sexually active, HIV negative, non-pregnant women were enrolled in three clinical trials in Kwazulu-Natal, South Africa. The prevalence of individual STIs Chlamydia trachomatis (CT), Neisseria gonorrhea (NG), syphilis, and Trichomonas vaginalis (TV) was assessed at screening; and incident infections were evaluated over a 24 month period.

Results: Overall, the combined study population of all three trials had a median age of 28 years (inter-quartile range (IQR):22-37), and a median duration of follow-up of 12 months. Prevalence of STIs (CT, NG, TV, or syphilis) was 13% at screening. The STI incidence was estimated to be 20/100 women years. Younger women (<25 years, p < 0.001), women who were unmarried (p < 0.001) and non-cohabiting women (p < 0.001) were shown to be at highest risk for incident STIs.

Conclusions: These results confirm the extremely high prevalence and incidence of STIs among women living in rural and urban communities of KwaZulu-Natal, South Africa, where the HIV epidemic is also particularly severe. These findings strongly suggest an urgent need to allocate resources for STI and HIV prevention that mainly target younger women.

Trial registration: Clinical Trials.gov, NCT00121459.

Keywords: HIV; Incidence; Kwa-Zulu Natal; Prevalence; Risk factors; Sexually transmitted infections; Women.

Figures

Figure 1
Figure 1
The Kaplan-Meier survival curves of STI incidence stratified by age (a), marital status (b) and cohabitation status (c).

References

    1. Johnson LF, Coetzee DJ, Dorrington RE. Sentinel surveillance of sexually transmitted infections in South Africa: a review. Sex Transm Infect. 2005;81:287–293. doi: 10.1136/sti.2004.013904. doi:10.1136/sti.2004.013904.
    1. Johnson LF, Dorrington RE, Bradshaw D, Coetzee DJ. The effect of syndromic management interventions on the prevalence of sexually transmitted infections in South Africa. Sex Reprod Healthc. 2011;2:13–20. doi: 10.1016/j.srhc.2010.08.006.
    1. Johnson L, Bradshaw D, Dorrington R. South African Comparative Risk Assessment Collaborating Group. The burden of disease attributable to sexually transmitted infections in South Africa in 2000. S Afr Med J. 2007;97:658–662.
    1. Aral SO, Over M, Manhart L, Holmes KK. In: Sexually Transmitted Infections. 2. Jamison DT, Breman JG, Measham AR, Alleyne G, Claeson M, Evans DB, Jha P, Mills A, Musgrove P, editor. Washington (DC): World Bank; 2006. Disease Control Priorities in Developing Countries.
    1. Cohen MS. Classical sexually transmitted diseases drive the spread of HIV-1: back to the future. J Infect Dis. 2012;206(1):1–2. doi: 10.1093/infdis/jis303.
    1. Lewis DA. Detection and management of acute HIV infections in patients with sexually transmitted infections: a window of opportunity for HIV prevention within South Africa? South Afr J Epidemiol Infect. 2012;27(4):149–155.
    1. Nel A, Mabude Z, Smit J, Kotze P, Arbuckle D, Wu J, van Niekerk N, van de Wijgert J. HIV incidence remains high in KwaZulu-Natal, South Africa: evidence from three districts. Plos One. 2012;7(4):e35278. doi: 10.1371/journal.pone.0035278. doi:10.1371/journal.pone.0035278.
    1. Ramjee G, Williams B, Gouws E, van Dyck E, De Deken B, Abdool Karim S. The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa. J Acquir Immune Defic Syndr. 2005;39:333–339. doi: 10.1097/01.qai.0000144445.44518.ea.
    1. Frolich JA, Abdool Karim Q, Mashego MM, Sturm AW, Abdool Karim SS. Opportunities for treating sexually transmitted infections and reducing HIV risk in rural South Africa. J Adv Nurs. 2007;60(4):377–383. doi: 10.1111/j.1365-2648.2007.04405.x. doi:10.1111/j.1365-2648.2007.04405.x.
    1. Wilkinson D, Connolly AM, Harrison A, Lurie M, Abdool Karim SS. Sexually transmitted disease syndromes in rural South Africa: results from health facility surveillance. Sex Trans Dis. 1998;25(1):20–23. doi: 10.1097/00007435-199801000-00005.
    1. Hoque ME. Reported risky sexual practices amongst female undergraduate students in Kwazulu-Natal, South Africa. Afr J Prm Health Care Fam Med. 2011;3(1):Art. #281,6. .
    1. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J. the MIRA team. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomized controlled trial. Lancet. 2007;370:251–261. doi: 10.1016/S0140-6736(07)60950-7.
    1. Nunn A, McCormack S, Crook AM, Pool R, Rutterford C, Hayes R. Microbicides development programme: design of a phase III trial to measure the efficacy of the vaginal microbicide PRO 2000/5 for HIV prevention. Trials. 2009;10:99. doi: 10.1186/1745-6215-10-99.
    1. Ramjee G, Kapiga S, Weiss S, Peterson L, Leburg C, Kelly C, Masse B. the HPTN 055 Study Team. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials. Experience from the HPTN 055 Study. J Acquir Immune Defic Syndr. 2008;47(1):93–100. doi: 10.1097/QAI.0b013e31815c71f7.
    1. Kapiga S, Kelly C, Weiss S, Daley T, Peterson L, Leburg C, Ramjee G. Risk factors for incidence of sexually transmitted infections among women in South Africa, Tanzania, and Zambia: Results from HPTN 055 Study. Sex Transm Dis. 2009;36(4):199–206. doi: 10.1097/OLQ.0b013e318191ba01.
    1. Ramjee G, Wand H, Whitaker C, McCormack S, Nunn A, Kelly C, Padian N. HIV incidence among non-pregnant women living in selected rural, semi-rural and urban areas in Kwazulu-Natal. AIDS Behav. 2012;16:2062–2071. doi: 10.1007/s10461-011-0043-7. doi:10.1007/s10461-011-0043-7.
    1. Mlisana K, Naicker N, Werner L, Roberts L, van Loggerenberg F, Baxter C, Passmore JS, Grobler AC, Sturm AW, Williamson C, Ronacher K, Walzl G, Abdool Karim SS. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206:6–14. doi: 10.1093/infdis/jis298.
    1. Abbai NS, Wand H, Ramjee G. Sexually transmitted infections in women participating in a biomedical intervention trial in Durban: prevalence, coinfections, and risk factors. J Sex Transm Dis. 2013;Article ID 358402:6. doi:10.1155/2013/358402.
    1. Feldblum PJ, Lie CC, Weaver MA, Van Damme L, Halpern V, Adeiga A, Bakare R, Schwartz J, Becker M, Solomon S. Baseline factors associated with incident HIV and STI in four microbicide trials. Sex Transm Dis. 2010;37(10):594–601.
    1. Marrazzo JM, Ramjee G, Nair G, Palanee T, Mkhize B, Nakabiito C, Taljaard M, Piper J, Gomez K, Chirenje M. Pre--exposure prophylaxis for HIV in Women: daily oral tenofovir, oral tenofovir/emtricitabine, or vaginal tenofovir gel in the VOICE Study (MTN 003) Atlanta: 20th Conference on Retroviruses and Opportunistic Infections; 2013. Abstract 26LB.
    1. Gertig DM, Kapiga SH, Shao JF, David J, Hunter DJ. Risk factors for sexually transmitted diseases among women attending family planning clinics in Dar-es-Salaam, Tanzania. Genitourin Med. 1997;73:39–43.
    1. Feldblum PJ, Kuyoh M, Omari M, Ryan KA, Bwayo JJ, Welsh M. Baseline STD prevalence in a community intervention trial of the female condom in Kenya. Sex Transm Inf. 2000;76:454–456. doi: 10.1136/sti.76.6.454.
    1. de Lima SV, de Torres S, Fa´bia Gazzaneo T, Cavalcante FBT, Silva ZP, Vale´ria Hora V, Thomas Diedrich T, de Carvalho Silva P, Gomes de Melo P, Dacal ARC1, de Carvalho EMF, Feldmeier H. Sexually transmitted infections in a female population in rural north-east Brazil: prevalence, morbidity and risk factors. Trop Med Int Health. 2003;8(7):595–603. doi: 10.1046/j.1365-3156.2003.01078.x.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere